Literature DB >> 1996533

Ambulatory blood pressure monitoring in the evaluation of drug efficacy.

E O'Brien1, K O'Malley, J Cox, A Stanton.   

Abstract

Conventional clinic measurement of blood pressure is influenced by many factors that make the technique unsuitable for the assessment of antihypertensive drug efficacy. The major drawback of conventional measurement is that it cannot indicate the duration of drug effect or the influence of antihypertensive drugs on nocturnal blood pressure. Noninvasive 24-hour ambulatory blood pressure measurement has a number of advantages over conventional measurement: it provides a profile of blood pressure over the 24-hour period; it detects white coat responders; it is free of regression to the mean and the placebo response, thereby making it possible to consider efficacy studies which need not have a placebo phase; it enables considerably more observations than is possible with clinic measurement by increasing the power of studies, which may reduce significantly the numbers of patients needed for antihypertensive drug studies. Twenty-four-hour ambulatory blood pressure measurement offers the opportunity to study antihypertensive drugs in fewer patients with greater accuracy than is possible with conventional clinic measurement and should be a mandatory requirement for such studies.

Entities:  

Mesh:

Year:  1991        PMID: 1996533     DOI: 10.1016/0002-8703(91)90611-k

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

2.  24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.

Authors:  T D Ruddy; J M Wright; D Savard; S P Handa; A Chockalingam; L Fischer; A P Boulet
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

3.  Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring.

Authors:  B S Sridhara; P Thomas; A Lahiri; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.

Authors:  T W Wilson; Y Lacourcière; C C Barnes
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

5.  When All Else Fails, Listen to the Patient: A Viewpoint on the Use of Ecological Momentary Assessment in Clinical Trials.

Authors:  Aaron M Mofsen; Thomas L Rodebaugh; Ginger E Nicol; Colin A Depp; J Philip Miller; Eric J Lenze
Journal:  JMIR Ment Health       Date:  2019-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.